Ifp Advisors, Inc Crispr Therapeutics Ag Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ifp Advisors, Inc holds 175 shares of CRSP stock, worth $8,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares

175

Previous 175 -0.0%

Holding current value

$8,678

Previous $11,000 18.18%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	BUY	$60.67 - $89.12 $4,550 - $6,684	75 Added 75.0%	175 $11,000
Q4 2023 Jan 09, 2024	SELL	$38.62 - $72.18 $8,380 - $15,663	-217 Reduced 68.45%	100 $6,000
Q3 2023 Oct 12, 2023	SELL	$45.39 - $59.0 $3,721 - $4,838	-82 Reduced 20.55%	317 $14,000
Q2 2023 Aug 04, 2023	SELL	$43.47 - $67.77 $260 - $406	-6 Reduced 1.48%	399 $22,000
Q1 2023 Apr 18, 2023	SELL	$41.0 - $56.12 $15,211 - $20,820	-371 Reduced 47.81%	405 $18,000
Q4 2022 Feb 07, 2023	SELL	$39.19 - $65.67 $12,619 - $21,145	-322 Reduced 29.33%	776 $66,000
Q3 2022 Nov 08, 2022	SELL	$61.1 - $83.78 $5,071 - $6,953	-83 Reduced 7.03%	1,098 $88,000
Q2 2022 Sep 06, 2022	BUY	$43.23 - $73.83 $51,054 - $87,193	1,181 New	1,181 $92,000
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $51,054 - $87,193	-1,181 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$53.19 - $79.24 $19,627 - $29,239	369 Added 45.44%	1,181 $74,000
Q1 2022 Aug 08, 2022	BUY	$53.19 - $79.24 $2,233 - $3,328	42 Added 5.45%	812 $50,000
Q4 2021 Jan 12, 2022	BUY	$70.09 - $111.29 $2,102 - $3,338	30 Added 4.05%	770 $58,000
Q3 2021 Oct 06, 2021	SELL	$110.2 - $156.64 $9,146 - $13,001	-83 Reduced 10.09%	740 $83,000
Q2 2021 Jul 13, 2021	SELL	$100.84 - $161.89 $3,126 - $5,018	-31 Reduced 3.63%	823 $133,000
Q1 2021 Apr 30, 2021	BUY	$110.72 - $210.04 $6,311 - $11,972	57 Added 7.15%	854 $104,000
Q4 2020 Jan 25, 2021	SELL	$79.67 - $173.23 $1,912 - $4,157	-24 Reduced 2.92%	797 $121,000
Q3 2020 Oct 29, 2020	BUY	$78.5 - $100.64 $14,915 - $19,121	190 Added 30.11%	821 $68,000
Q2 2020 Aug 05, 2020	BUY	$38.5 - $76.05 $577 - $1,140	15 Added 2.44%	631 $48,000
Q1 2020 May 12, 2020	BUY	$33.68 - $62.53 $16,840 - $31,265	500 Added 431.03%	616 $27,000
Q4 2019 Jan 17, 2020	SELL	$36.68 - $73.13 $880 - $1,755	-24 Reduced 17.14%	116 $8,000
Q3 2019 Nov 07, 2019	BUY	$40.99 - $52.56 $4,099 - $5,256	100 Added 250.0%	140 $6,000
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $19,053 - $27,791	-680 Reduced 94.44%	40 $1,000
Q4 2018 Jan 23, 2019	BUY	$22.73 - $42.34 $340 - $635	15 Added 2.13%	720 $20,000
Q3 2018 Oct 25, 2018	SELL	$44.35 - $65.71 $6,563 - $9,725	-148 Reduced 17.35%	705 $0
Q2 2018 Aug 07, 2018	BUY	$42.62 - $73.59 $19,306 - $33,336	453 Added 113.25%	853 $0
Q1 2018 Jun 03, 2019	BUY	$23.52 - $58.17 $1,764 - $4,362	75 Added 23.08%	400 $9,000
Q1 2018 May 09, 2018	SELL	$23.52 - $58.17 $1,764 - $4,362	-75 Reduced 18.75%	325 $0
Q4 2017 Jan 24, 2018	BUY	$16.95 - $23.48 $6,102 - $8,452	360 Added 900.0%	400 $0
Q1 2016 Jun 03, 2019	BUY	N/A	40	40 $1,000

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account